pgbkt-7 vector (Becton Dickinson)
90
Structured Review
Becton Dickinson
pgbkt-7 vector
Pgbkt 7 Vector, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vector+pgbkt7/pgbkt+7+vector/pm21393573-34-14-16
Average 90 stars, based on 1 article reviews
Pgbkt 7 Vector, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vector+pgbkt7/pgbkt+7+vector/pm21393573-34-14-16
Average 90 stars, based on 1 article reviews
pgbkt-7 vector - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Clone Assay:Article Title: VSTM2L is a novel secreted antagonist of the neuroprotective peptide Humanin. Article Snippet: Humanin (HN) is a 24-residue peptide displaying a protective activity in vitro against a range of cytotoxic and neurotoxic insults, as well as mediating in vivo amelioration of Alzheimer disease (AD)-related memory impairment in experimental models.. Published evidence suggests that the mechanisms through which HN exerts its cytoand neuroprotective activity may include its secretion and binding to membraneassociated receptors.. Here, we describe the identification of a new modulator of HN neuroprotective activity, V-set and transmembrane domain containing 2 like (VSTM2L), previously known as C20orf102. Plasmid Preparation:Article Title: VSTM2L is a novel secreted antagonist of the neuroprotective peptide Humanin. Article Snippet: Humanin (HN) is a 24-residue peptide displaying a protective activity in vitro against a range of cytotoxic and neurotoxic insults, as well as mediating in vivo amelioration of Alzheimer disease (AD)-related memory impairment in experimental models.. Published evidence suggests that the mechanisms through which HN exerts its cytoand neuroprotective activity may include its secretion and binding to membraneassociated receptors.. Here, we describe the identification of a new modulator of HN neuroprotective activity, V-set and transmembrane domain containing 2 like (VSTM2L), previously known as C20orf102. |